These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

163 related items for PubMed ID: 37364785

  • 21. Characterizing the Surface Roughness Length Scales of Lactose Carrier Particles in Dry Powder Inhalers.
    Tan BMJ, Chan LW, Heng PWS.
    Mol Pharm; 2018 Apr 02; 15(4):1635-1642. PubMed ID: 29490144
    [Abstract] [Full Text] [Related]

  • 22. Insights into the roles of carrier microstructure in adhesive/carrier-based dry powder inhalation mixtures: Carrier porosity and fine particle content.
    Shalash AO, Molokhia AM, Elsayed MM.
    Eur J Pharm Biopharm; 2015 Oct 02; 96():291-303. PubMed ID: 26275831
    [Abstract] [Full Text] [Related]

  • 23. Development and characterization of meropenem dry powder inhaler formulation for pulmonary drug delivery.
    Muneer S, Wang T, Rintoul L, Ayoko GA, Islam N, Izake EL.
    Int J Pharm; 2020 Sep 25; 587():119684. PubMed ID: 32736016
    [Abstract] [Full Text] [Related]

  • 24. Dry powder inhalers: study of the parameters influencing adhesion and dispersion of fluticasone propionate.
    Le VN, Hoang Thi TH, Robins E, Flament MP.
    AAPS PharmSciTech; 2012 Jun 25; 13(2):477-84. PubMed ID: 22399285
    [Abstract] [Full Text] [Related]

  • 25.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 26.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 27. Low density, good flowability cyclodextrin-raffinose binary carrier for dry powder inhaler: anti-hygroscopicity and aerosolization performance enhancement.
    Zhao Z, Huang Z, Zhang X, Huang Y, Cui Y, Ma C, Wang G, Freeman T, Lu XY, Pan X, Wu C.
    Expert Opin Drug Deliv; 2018 May 25; 15(5):443-457. PubMed ID: 29532682
    [Abstract] [Full Text] [Related]

  • 28. The effect of mixing on the dispersibility of adhesive mixtures for inhalation. Comparison of high shear and Turbula mixers.
    Thalberg K, Ivarsson L, Svensson M, Elfman P, Ohlsson A, Stuckel J, Lyberg AM.
    Eur J Pharm Sci; 2024 Feb 01; 193():106679. PubMed ID: 38128841
    [Abstract] [Full Text] [Related]

  • 29.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 30. Dispersibility of lactose fines as compared to API in dry powders for inhalation.
    Thalberg K, Åslund S, Skogevall M, Andersson P.
    Int J Pharm; 2016 May 17; 504(1-2):27-38. PubMed ID: 26965200
    [Abstract] [Full Text] [Related]

  • 31.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 32.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 33. Investigation into the Manufacture and Properties of Inhalable High-Dose Dry Powders Produced by Comilling API and Lactose with Magnesium Stearate.
    Lau M, Young PM, Traini D.
    AAPS PharmSciTech; 2017 Aug 17; 18(6):2248-2259. PubMed ID: 28070849
    [Abstract] [Full Text] [Related]

  • 34.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 35.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 36.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 37.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 38. Puerarin dry powder inhaler formulations for pulmonary delivery: Development and characterization.
    Rashid MA, Muneer S, Wang T, Alhamhoom Y, Rintoul L, Izake EL, Islam N.
    PLoS One; 2021 Aug 17; 16(4):e0249683. PubMed ID: 33848310
    [Abstract] [Full Text] [Related]

  • 39.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 40.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

    Page: [Previous] [Next] [New Search]
    of 9.